Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Francesco Vittorio Costa; Orietta Zaniolo
   Simvastatina. Una maggiorenne di belle speranze: tra clinica ed economia sanitaria
   Farmeconomia e percorsi terapeutici
   
   Francesco Vittorio Costa e Orietta Zaniolo, "Simvastatina. Una maggiorenne di belle speranze: tra clinica ed economia sanitaria", Farmeconomia e percorsi terapeutici, 8(1), 2007, pp. 27-45
2. Mario Eandi; Carlo Salvarani
   Analisi farmacoeconomiche dei trattamenti biologici per la cura dell'artrite psoriasica
   Farmeconomia e percorsi terapeutici
   
   Mario Eandi e Carlo Salvarani, "Analisi farmacoeconomiche dei trattamenti biologici per la cura dell'artrite psoriasica", Farmeconomia e percorsi terapeutici, 7(3), 2006, pp. 171-186
3. Simona de Portu; Enrica Menditto; Lorenzo G. Mantovani
   Valutazione economica dello studio CARDS
   Farmeconomia e percorsi terapeutici
   
   Simona de Portu et al., "Valutazione economica dello studio CARDS", Farmeconomia e percorsi terapeutici, 7(3), 2006, pp. 193-197
4. Orietta Zaniolo
   Vitamina D3: profilo farmacoeconomico nella prevenzione dell'osteoporosi e delle sue complicanze
   Farmeconomia e percorsi terapeutici
   
   Orietta Zaniolo, "Vitamina D3: profilo farmacoeconomico nella prevenzione dell'osteoporosi e delle sue complicanze", Farmeconomia e percorsi terapeutici, 7(1), 2006, pp. 71-82
5. Carlo Lazzaro; Manolo Beelke
   Analisi costo-efficacia di 90Y-ibritumomab tiuxetano (Zevalin) vs. terapie attualmente disponibili nel trattamento dei pazienti affetti da Linfoma Non-Hodgkin (LNH) refrattario o recidivato
   Farmeconomia e percorsi terapeutici
   
   Carlo Lazzaro e Manolo Beelke, "Analisi costo-efficacia di 90Y-ibritumomab tiuxetano (Zevalin) vs. terapie attualmente disponibili nel trattamento dei pazienti affetti da Linfoma Non-Hodgkin (LNH) refrattario o recidivato", Farmeconomia e percorsi terapeutici, 6(4), 2005, pp. 317-332
6. Mario Eandi
   Analisi costo-efficacia di amfotericina B liposomiale (L-AmB) versus amfotericina B complesso lipidico (ABLC) nel trattamento empirico della neutropenia febbrile
   Farmeconomia e percorsi terapeutici
   
   Mario Eandi, "Analisi costo-efficacia di amfotericina B liposomiale (L-AmB) versus amfotericina B complesso lipidico (ABLC) nel trattamento empirico della neutropenia febbrile", Farmeconomia e percorsi terapeutici, 6(4), 2005, pp. 333-347
7. Orietta Zaniolo; Lorenzo Pradelli; Mario Eandi
   Costo/efficacia della prevenzione di infezioni alle prime vie aeree mediante un estratto batterico immunostimolante aspecifico (OM-85)
   Farmeconomia e percorsi terapeutici
   
   Orietta Zaniolo et al., "Costo/efficacia della prevenzione di infezioni alle prime vie aeree mediante un estratto batterico immunostimolante aspecifico (OM-85)", Farmeconomia e percorsi terapeutici, 6(3), 2005, pp. 169-184
8. paolo Marchettini; Lisa Da Deppo; Lorenzo Pradelli
   Pregabalin versus gabapentin nel trattamento dei pazienti con neuropatia periferica: adattamento di un modello internazionale per la valutazione di costo/efficia e costo/utilità nella realtà nazionale
   Farmeconomia e percorsi terapeutici
   
   paolo Marchettini et al., "Pregabalin versus gabapentin nel trattamento dei pazienti con neuropatia periferica: adattamento di un modello internazionale per la valutazione di costo/efficia e costo/utilità nella realtà nazionale", Farmeconomia e percorsi terapeutici, 6(3), 2005, pp. 243-250
9. Bombardieri, E; Aliberti, G; De Graaf, C; Pauwels, E; Crippa, F
   Positron emission tomography (PET) and other nuclear medicine modalities in staging gastrointestinal cancer
   SEMINARS IN SURGICAL ONCOLOGY
   
   E. Bombardieri et al., "Positron emission tomography (PET) and other nuclear medicine modalities in staging gastrointestinal cancer", SEM SURG ON, 20(2), 2001, pp. 134-146
10. Barton, LL; Grant, KL; Lemen, RJ
    Respiratory syncytial virus immune globulin: Decisions and costs
    PEDIATRIC PULMONOLOGY
    
    L.L. Barton et al., "Respiratory syncytial virus immune globulin: Decisions and costs", PEDIAT PULM, 32(1), 2001, pp. 20-28
11. Baltensperger, C; Grawe, K
    Psychotherapy from a health-economics point of view
    ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE
    
    C. Baltensperger e K. Grawe, "Psychotherapy from a health-economics point of view", Z KLIN P P, 30(1), 2001, pp. 10-21
12. Gisbert, JP; Cruzado, AI; Benito, LM; Carpio, D; Perez-Poveda, JJ; Gonzalez, L; de Pedro, A; Valbuena, M; Prieto, B; Cabrera, MM; Cantero, J; Pajares, JM
    Helicobacter pylori "test-and-scope" strategy for dyspeptic patients. Is it useful and safe?
    DIGESTIVE AND LIVER DISEASE
    
    J.P. Gisbert et al., "Helicobacter pylori "test-and-scope" strategy for dyspeptic patients. Is it useful and safe?", DIG LIVER D, 33(7), 2001, pp. 539-545
13. La Vecchia, C
    Reducing colorectal cancer through faecal occult blood screening: review of the evidence
    DIGESTIVE AND LIVER DISEASE
    
    C. La Vecchia, "Reducing colorectal cancer through faecal occult blood screening: review of the evidence", DIG LIVER D, 33(6), 2001, pp. 445-448
14. Wehr, E
    Evidence-based health care coverage for children: Proceed with caution
    AMBULATORY PEDIATRICS
    
    E. Wehr, "Evidence-based health care coverage for children: Proceed with caution", AMBU PEDIAT, 1(1), 2001, pp. 23-27
15. Collins, J
    Cost-effectiveness of in vitro fertilization
    SEMINARS IN REPRODUCTIVE MEDICINE
    
    J. Collins, "Cost-effectiveness of in vitro fertilization", SEMIN REP M, 19(3), 2001, pp. 279-289
16. Laufer, FN
    Cost-effectiveness of syringe exchange as an HIV prevention strategy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    F.N. Laufer, "Cost-effectiveness of syringe exchange as an HIV prevention strategy", J ACQ IMM D, 28(3), 2001, pp. 273-278
17. Kahn, JG; Kegeles, SM; Hays, R; Beltzer, N
    Cost-effectiveness of the Mpowerment Project, a community-level intervention for young gay men
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    J.G. Kahn et al., "Cost-effectiveness of the Mpowerment Project, a community-level intervention for young gay men", J ACQ IMM D, 27(5), 2001, pp. 482-491
18. March, L; Lapsley, H
    What are the costs to society and the potential benefits from the effective management of early rheumatoid arthritis?
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    L. March e H. Lapsley, "What are the costs to society and the potential benefits from the effective management of early rheumatoid arthritis?", BEST PR R C, 15(1), 2001, pp. 171-185
19. Shaw, LJ; Berman, DS; Miller, DD
    Cost-effectiveness of myocardial perfusion imaging in the evaluation of patients with known or suspected coronary artery disease
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    L.J. Shaw et al., "Cost-effectiveness of myocardial perfusion imaging in the evaluation of patients with known or suspected coronary artery disease", EUR H J SUP, 3(F), 2001, pp. F15-F18
20. Henderson, J; McCandlish, R; Kumiega, L; Petrou, S
    Systematic review of economic aspects of alternative modes of delivery
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    
    J. Henderson et al., "Systematic review of economic aspects of alternative modes of delivery", BR J OBST G, 108(2), 2001, pp. 149-157
21. Sowter, MC; Farquhar, CM; Gudex, G
    An economic evaluation of single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured ectopic pregnancy
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    
    M.C. Sowter et al., "An economic evaluation of single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured ectopic pregnancy", BR J OBST G, 108(2), 2001, pp. 204-212
22. Munsat, TL
    Slowing down ALS - is this good or bad?
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    
    T.L. Munsat, "Slowing down ALS - is this good or bad?", AMYOTROPH L, 2, 2001, pp. S19-S22
23. Berdeu, D; Sauze, L; Ha-Vinh, P; Blum-Boisgard, C
    Cost-effectiveness analysis of treatments for phimosis: a comparison of surgical and medicinal approaches and their economic effect
    BJU INTERNATIONAL
    
    D. Berdeu et al., "Cost-effectiveness analysis of treatments for phimosis: a comparison of surgical and medicinal approaches and their economic effect", BJU INT, 87(3), 2001, pp. 239-244
24. Lambert, CM
    Medical therapy for rheumatoid arthritis - value for money?
    RHEUMATOLOGY
    
    C.M. Lambert, "Medical therapy for rheumatoid arthritis - value for money?", RHEUMATOLOG, 40(9), 2001, pp. 961-964
25. Ben Sedrine, W; Radican, L; Reginster, JY
    On conducting burden-of-osteoporosis studies: a review of the core concepts and practical issues. A study carried out under the auspices of a WHO Collaborating Center
    RHEUMATOLOGY
    
    W. Ben Sedrine et al., "On conducting burden-of-osteoporosis studies: a review of the core concepts and practical issues. A study carried out under the auspices of a WHO Collaborating Center", RHEUMATOLOG, 40(1), 2001, pp. 7-14
26. Frund, R; Techert, J; Strotzer, M; Borner, W; Tsakpinis, A; Feuerbach, S
    The PACS concept of the University of Regensburg
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    
    R. Frund et al., "The PACS concept of the University of Regensburg", ROFO-F RONT, 173(4), 2001, pp. 362-367
27. Sabel, M; Aichinger, U; Schulz-Wendtland, R
    Radiation exposure in X-ray mammography - A review.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    
    M. Sabel et al., "Radiation exposure in X-ray mammography - A review.", ROFO-F RONT, 173(2), 2001, pp. 79-91
28. Schmitt, KP; Boehm, T; Fleck, M; Kaiser, WA
    Cost-effectiveness of MR-imaging in the preoperative workup of suspicious breast lesions.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    
    K.P. Schmitt et al., "Cost-effectiveness of MR-imaging in the preoperative workup of suspicious breast lesions.", ROFO-F RONT, 173(10), 2001, pp. 898-901
29. Gozzoli, V; Palmer, AJ; Brandt, A; Spinas, GA
    Economic and clinical impact of alternative disease management strategies for secondary prevention in type 2 diabetes in the Swiss setting
    SWISS MEDICAL WEEKLY
    
    V. Gozzoli et al., "Economic and clinical impact of alternative disease management strategies for secondary prevention in type 2 diabetes in the Swiss setting", SWISS MED W, 131(21-22), 2001, pp. 303-310
30. Lundstrom, M; Roos, P; Brege, KG; Floren, I; Stenevi, U; Thorburn, W
    Cataract surgery and effectiveness 2. An index approach for the measurement of output and efficiency of cataract surgery at different surgery departments
    ACTA OPHTHALMOLOGICA SCANDINAVICA
    
    M. Lundstrom et al., "Cataract surgery and effectiveness 2. An index approach for the measurement of output and efficiency of cataract surgery at different surgery departments", ACT OPHTH S, 79(2), 2001, pp. 147-153
31. Ostergren, JB; Bjorholt, I; Andersson, F; Kahan, T
    Pharmaeoeconomic impact of HOPE
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    J.B. Ostergren et al., "Pharmaeoeconomic impact of HOPE", INT J CL PR, 2001, pp. 19-21
32. Martin, F; Bower, M
    Anal intraepithelial neoplasia in HIV positive people
    SEXUALLY TRANSMITTED INFECTIONS
    
    F. Martin e M. Bower, "Anal intraepithelial neoplasia in HIV positive people", SEX TRANS I, 77(5), 2001, pp. 327-331
33. van Valkengoed, IGM; Postma, MJ; Morre, SA; van den Brule, AJC; Meijer, CJLM; Bouter, LM; Boeke, AJP
    Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens
    SEXUALLY TRANSMITTED INFECTIONS
    
    I.G.M. van Valkengoed et al., "Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens", SEX TRANS I, 77(4), 2001, pp. 276-282
34. Burstein, GR; Zenilman, JM; Gaydos, CA; Diener-West, M; Howell, MR; Brathwaite, W; Quinn, TC
    Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females
    SEXUALLY TRANSMITTED INFECTIONS
    
    G.R. Burstein et al., "Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females", SEX TRANS I, 77(1), 2001, pp. 26-32
35. Benoit, RM; Gronberg, H; Naslund, MJ
    A quantitative analysis of the costs and benefits of prostate cancer screening
    PROSTATE CANCER AND PROSTATIC DISEASES
    
    R.M. Benoit et al., "A quantitative analysis of the costs and benefits of prostate cancer screening", PROSTATE C, 4(3), 2001, pp. 138-145
36. Utzinger, J; Tozan, Y; Singer, BH
    Efficacy and cost-effectiveness of environmental management for malaria control
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    J. Utzinger et al., "Efficacy and cost-effectiveness of environmental management for malaria control", TR MED I H, 6(9), 2001, pp. 677-687
37. Goodman, CA; Mnzava, AEP; Dlamini, SS; Sharp, BL; Mthembu, DJ; Gumede, JK
    Comparison of the cost and cost-effectiveness of insecticide-treated bednets and residual house-spraying in KwaZulu-Natal, South Africa
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    C.A. Goodman et al., "Comparison of the cost and cost-effectiveness of insecticide-treated bednets and residual house-spraying in KwaZulu-Natal, South Africa", TR MED I H, 6(4), 2001, pp. 280-295
38. Blackwell, SC; Tomlinson, MW; Berman, S; Redman, ME; Hassan, SS; Berry, SM; Hallak, M; Sorokin, Y; Cotton, DB
    The use of magnesium sulfate to prevent seizures in the pre-eclamptic gravida: a cost-effectiveness analysis
    PRENATAL AND NEONATAL MEDICINE
    
    S.C. Blackwell et al., "The use of magnesium sulfate to prevent seizures in the pre-eclamptic gravida: a cost-effectiveness analysis", PRENAT N M, 6(5), 2001, pp. 310-317
39. Hilleman, DE
    Pharmacoeconomics of combination antihypertensive therapy
    BLOOD PRESSURE MONITORING
    
    D.E. Hilleman, "Pharmacoeconomics of combination antihypertensive therapy", BL PRESS M, 6, 2001, pp. S31-S36
40. Tually, P; Walker, J; Cowell, S
    The effect of nuclear medicine telediagnosis on diagnostic pathways and management in rural and remote regions of Western Australia
    JOURNAL OF TELEMEDICINE AND TELECARE
    
    P. Tually et al., "The effect of nuclear medicine telediagnosis on diagnostic pathways and management in rural and remote regions of Western Australia", J TELEMED T, 7, 2001, pp. 50-53
41. Vuletic, S
    Teleradiology in Croatia
    JOURNAL OF TELEMEDICINE AND TELECARE
    
    S. Vuletic, "Teleradiology in Croatia", J TELEMED T, 7, 2001, pp. S73-S75
42. Sanders, GD; Nease, RF; Owens, DK
    Publishing web-based guidelines using interactive decision models
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE
    
    G.D. Sanders et al., "Publishing web-based guidelines using interactive decision models", J EVAL CL P, 7(2), 2001, pp. 175-189
43. Zijlstra, F
    Acute myocardial infarction: primary angioplasty
    HEART
    
    F. Zijlstra, "Acute myocardial infarction: primary angioplasty", HEART, 85(6), 2001, pp. 705-709
44. Malik, IS; Bhatia, VK; Kooner, JS
    Cost effectiveness of ramipril treatment for cardiovascular risk reduction
    HEART
    
    I.S. Malik et al., "Cost effectiveness of ramipril treatment for cardiovascular risk reduction", HEART, 85(5), 2001, pp. 539-543
45. Thornett, A
    Developing models for assessing the cost-effectiveness of antidepressants in primary care
    PRIMARY CARE PSYCHIATRY
    
    A. Thornett, "Developing models for assessing the cost-effectiveness of antidepressants in primary care", PRIM CARE P, 7(2), 2001, pp. 69-74
46. Harrington, KJ
    Liposomal cancer chemotherapy: current clinical applications and future prospects
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    K.J. Harrington, "Liposomal cancer chemotherapy: current clinical applications and future prospects", EXPERT OP I, 10(6), 2001, pp. 1045-1061
47. Johnson, GD; Patil, GP
    Cost analysis of composite sampling for classification
    ENVIRONMENTAL AND ECOLOGICAL STATISTICS
    
    G.D. Johnson e G.P. Patil, "Cost analysis of composite sampling for classification", ENV ECOL ST, 8(2), 2001, pp. 91-107
48. Myers, RP; Hilsden, RJ; Lee, SS
    Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C
    JOURNAL OF VIRAL HEPATITIS
    
    R.P. Myers et al., "Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C", J VIRAL HEP, 8(4), 2001, pp. 249-255
49. Fischer, K; Van der Bom, JG; Mauser-Bunschoten, EP; Roosendaal, G; Prejs, R; Grobbee, DE; Van den Berg, HM
    Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy
    HAEMOPHILIA
    
    K. Fischer et al., "Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy", HAEMOPHILIA, 7(5), 2001, pp. 446-452
50. Bjorkman, S; Shapiro, AD; Berntorp, E
    Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis
    HAEMOPHILIA
    
    S. Bjorkman et al., "Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis", HAEMOPHILIA, 7(2), 2001, pp. 133-139
51. Chaiyakunapruk, N; Boudreau, D; Ramsey, SD
    Pharmaco-economic impact of HMG-CoA reductase inhibitors in type 2 diabetes
    JOURNAL OF CARDIOVASCULAR RISK
    
    N. Chaiyakunapruk et al., "Pharmaco-economic impact of HMG-CoA reductase inhibitors in type 2 diabetes", J CARD RISK, 8(3), 2001, pp. 127-132
52. Sakthong, P; Tangphao, O; Eiam-Ong, S; Kamolratanakul, P; Supakankunti, S; Himathongkam, T; Yathavong, K
    Cost-effectiveness of using angiotensin-converting enzyme inhibitors to slow nephropathy in normotensive patients with diabetes type II and microalbuminuria
    NEPHROLOGY
    
    P. Sakthong et al., "Cost-effectiveness of using angiotensin-converting enzyme inhibitors to slow nephropathy in normotensive patients with diabetes type II and microalbuminuria", NEPHROLOGY, 6(2), 2001, pp. 71-77
53. Bouza, E; San Juan, R; Munoz, P; Voss, A; Kluytmans, J
    A European perspective on nosocomial urinary tract infections I. Report onthe microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study)
    CLINICAL MICROBIOLOGY AND INFECTION
    
    E. Bouza et al., "A European perspective on nosocomial urinary tract infections I. Report onthe microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study)", CL MICRO IN, 7(10), 2001, pp. 523-531
54. Plans-Rubio, P
    Management of pharmaceutical resources for the primary prevention of coronary heart disease in Catalonia (Spain) based on efficiency and equity
    DISEASE MANAGEMENT & HEALTH OUTCOMES
    
    P. Plans-Rubio, "Management of pharmaceutical resources for the primary prevention of coronary heart disease in Catalonia (Spain) based on efficiency and equity", DIS MANAG H, 9(9), 2001, pp. 495-506
55. Bonds, DE; Freedberg, KA
    Combining utility measurements - Exploring different approaches
    DISEASE MANAGEMENT & HEALTH OUTCOMES
    
    D.E. Bonds e K.A. Freedberg, "Combining utility measurements - Exploring different approaches", DIS MANAG H, 9(9), 2001, pp. 507-516
56. Koff, RS
    Disease management programs for hepatitis C - A team approach to setting goals
    DISEASE MANAGEMENT & HEALTH OUTCOMES
    
    R.S. Koff, "Disease management programs for hepatitis C - A team approach to setting goals", DIS MANAG H, 9(8), 2001, pp. 431-439
57. Batra, N
    Hepatitis C screening and treatment versus liver transplantation - A financial option appraisal and commissioning model for purchasers
    DISEASE MANAGEMENT & HEALTH OUTCOMES
    
    N. Batra, "Hepatitis C screening and treatment versus liver transplantation - A financial option appraisal and commissioning model for purchasers", DIS MANAG H, 9(7), 2001, pp. 371-384
58. Greenwood, T
    Comparing smoking cessation interventions for work-site disease management
    DISEASE MANAGEMENT & HEALTH OUTCOMES
    
    T. Greenwood, "Comparing smoking cessation interventions for work-site disease management", DIS MANAG H, 9(10), 2001, pp. 565-576
59. Frank, L; Revicki, DA; Sorensen, SV; Shih, YCT
    The economics of selective serotonin reuptake inhibitors in depression - Acritical review
    CNS DRUGS
    
    L. Frank et al., "The economics of selective serotonin reuptake inhibitors in depression - Acritical review", CNS DRUGS, 15(1), 2001, pp. 59-83
60. Maio, V; Girts, TK; Lofland, JH; Nash, DB
    Pharmacoeconomic fellowships - The need for outcome measures
    PHARMACOECONOMICS
    
    V. Maio et al., "Pharmacoeconomic fellowships - The need for outcome measures", PHARMACOECO, 19(8), 2001, pp. 795-802
61. Sendi, P; Palmer, AJ; Gafni, A; Battegay, M
    Highly active antiretroviral therapy - Pharmacoeconomic issues in the management of HIV infection
    PHARMACOECONOMICS
    
    P. Sendi et al., "Highly active antiretroviral therapy - Pharmacoeconomic issues in the management of HIV infection", PHARMACOECO, 19(7), 2001, pp. 709-713
62. Liljas, B; Lindgren, B
    On individual preferences and aggregation in economic evaluation in healthcare
    PHARMACOECONOMICS
    
    B. Liljas e B. Lindgren, "On individual preferences and aggregation in economic evaluation in healthcare", PHARMACOECO, 19(4), 2001, pp. 323-335
63. Ambrosioni, E
    Pharmacoeconomics of hypertension management - The place of combination therapy
    PHARMACOECONOMICS
    
    E. Ambrosioni, "Pharmacoeconomics of hypertension management - The place of combination therapy", PHARMACOECO, 19(4), 2001, pp. 337-347
64. Plosker, GL; Perry, CM; Goa, KL
    Efavirenz - A pharmacoeconomic review of its use in HIV infection
    PHARMACOECONOMICS
    
    G.L. Plosker et al., "Efavirenz - A pharmacoeconomic review of its use in HIV infection", PHARMACOECO, 19(4), 2001, pp. 421-440
65. Plosker, GL; Hurst, M
    Paclitaxel - A pharmacoeconomic review of its use in non-small cell lung cancer
    PHARMACOECONOMICS
    
    G.L. Plosker e M. Hurst, "Paclitaxel - A pharmacoeconomic review of its use in non-small cell lung cancer", PHARMACOECO, 19(11), 2001, pp. 1111-1134
66. Young, M; Plosker, GL
    Piperacillin/tazobactam - A pharmacoeconomic review of its use in moderateto severe bacterial infections
    PHARMACOECONOMICS
    
    M. Young e G.L. Plosker, "Piperacillin/tazobactam - A pharmacoeconomic review of its use in moderateto severe bacterial infections", PHARMACOECO, 19(11), 2001, pp. 1135-1175
67. Joish, VN; Armstrong, EP
    Which antifungal agent for onychomycosis? A pharmacoeconomic analysis
    PHARMACOECONOMICS
    
    V.N. Joish e E.P. Armstrong, "Which antifungal agent for onychomycosis? A pharmacoeconomic analysis", PHARMACOECO, 19(10), 2001, pp. 983-1002
68. Burke, TA; Zabinski, RA; Pettitt, D; Maniadakis, N; Maurath, CJ; Goldstein, JL
    A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis
    PHARMACOECONOMICS
    
    T.A. Burke et al., "A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis", PHARMACOECO, 19(1), 2001, pp. 33-47
69. Caro, JJ; O'Brien, JA; Migliaccio-Walle, K; Raggio, G
    Economic analysis of initial HIV treatment - Efavirenz- versus indinavir-containing triple therapy
    PHARMACOECONOMICS
    
    J.J. Caro et al., "Economic analysis of initial HIV treatment - Efavirenz- versus indinavir-containing triple therapy", PHARMACOECO, 19(1), 2001, pp. 95-104
70. Sculpher, M
    Using economic evaluations to reduce the burden of asthma and chronic obstructive pulmonary disease
    PHARMACOECONOMICS
    
    M. Sculpher, "Using economic evaluations to reduce the burden of asthma and chronic obstructive pulmonary disease", PHARMACOECO, 19, 2001, pp. 21-25
71. Dunn, EC; Small, RE
    Economics of antihypertensive therapy in the elderly
    DRUGS & AGING
    
    E.C. Dunn e R.E. Small, "Economics of antihypertensive therapy in the elderly", DRUG AGING, 18(7), 2001, pp. 515-525
72. Hemels, MEH; Lanctot, KL; Iskedjian, M; Einarson, TR
    Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia
    DRUGS & AGING
    
    M.E.H. Hemels et al., "Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia", DRUG AGING, 18(7), 2001, pp. 527-550
73. Chapuis, F; Thiebaut, A; Bataillard, A; Piens, MA; Lafuma, A; Nicolle, MC; Auray, JP
    Economic consequences of invasive aspergillosis due to Aspergillus or to other filamentous fungal infection in patients treated for acute myeloid leukemia and preventive treatments modeling
    JOURNAL DE MYCOLOGIE MEDICALE
    
    F. Chapuis et al., "Economic consequences of invasive aspergillosis due to Aspergillus or to other filamentous fungal infection in patients treated for acute myeloid leukemia and preventive treatments modeling", J MYCOL MED, 11(2), 2001, pp. 67-72
74. Koretz, RL
    Hepatitis C - The case against treatment
    EUROPEAN JOURNAL OF SURGERY
    
    R.L. Koretz, "Hepatitis C - The case against treatment", EURO J SURG, 167, 2001, pp. 34-39
75. Nisam, S
    A prophylactic ICD? Who are the patients? What is the device?
    EUROPACE
    
    S. Nisam, "A prophylactic ICD? Who are the patients? What is the device?", EUROPACE, 3(4), 2001, pp. 269-274
76. Fragakis, N; Kotsakis, A; Patel, N; Bostock, J; Rosenthal, E; Holt, P; Bucknall, C; Gill, J
    Atrial flutter ablation: Efficacy and cost-effectiveness of a single decapolar electrode to demonstrate bidirectional isthmus block
    EUROPACE
    
    N. Fragakis et al., "Atrial flutter ablation: Efficacy and cost-effectiveness of a single decapolar electrode to demonstrate bidirectional isthmus block", EUROPACE, 3(4), 2001, pp. 304-310
77. Varghese, B; Peterman, TA
    Cost-effectiveness of HIV counseling and testing in US prisons
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
    
    B. Varghese e T.A. Peterman, "Cost-effectiveness of HIV counseling and testing in US prisons", J URBAN H, 78(2), 2001, pp. 304-312
78. Holder, HD
    Prevention research and its actual application to health services
    JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH
    
    H.D. Holder, "Prevention research and its actual application to health services", J BEHAV H S, 28(2), 2001, pp. 118-129
79. Byrnes, V; Ryan, E; Barrett, S; Kenny, P; Mayne, P; Crowe, J
    Genetic hemochromatosis, a Celtic disease: Is it now time for population screening?
    GENETIC TESTING
    
    V. Byrnes et al., "Genetic hemochromatosis, a Celtic disease: Is it now time for population screening?", GENET TEST, 5(2), 2001, pp. 127-130
80. Vogel, R; Schaefer, E
    Should all patients with cardiovascular disease receive statin therapy?
    AMERICAN JOURNAL OF MANAGED CARE
    
    R. Vogel e E. Schaefer, "Should all patients with cardiovascular disease receive statin therapy?", AM J M CARE, 7(5), 2001, pp. S117-S124
81. Spyropoulos, AC
    The use of a protocol for the treatment of deep vein thrombosis
    AMERICAN JOURNAL OF MANAGED CARE
    
    A.C. Spyropoulos, "The use of a protocol for the treatment of deep vein thrombosis", AM J M CARE, 7(17), 2001, pp. S553-S558
82. DiTusa, L; Luzier, AB; Brady, G; Reinhardt, M; Snyder, BD
    A pharmacy-based approach to cholesterol management
    AMERICAN JOURNAL OF MANAGED CARE
    
    L. DiTusa et al., "A pharmacy-based approach to cholesterol management", AM J M CARE, 7(10), 2001, pp. 973-979
83. Beers, MH; Baran, RW; Frenia, K
    Drugs and the elderly, part 2: Strategies for improving prescribing in a managed care environment
    AMERICAN JOURNAL OF MANAGED CARE
    
    M.H. Beers et al., "Drugs and the elderly, part 2: Strategies for improving prescribing in a managed care environment", AM J M CARE, 7(1), 2001, pp. 69-72
84. Britto, MT; Atherton, HD; De Witt, TG
    Immunizing adolescents in private practice: Lessons learned from hepatitisB
    AMERICAN JOURNAL OF MANAGED CARE
    
    M.T. Britto et al., "Immunizing adolescents in private practice: Lessons learned from hepatitisB", AM J M CARE, 2001, pp. 127-134
85. Yamamoto, S; Kaneko, H; Konagaya, T; Mori, S; Kotera, H; Hayakawa, T; Yamaguchi, C; Uruma, M; Kusugami, K; Mitsuma, T
    Interactions among gastric somatostatin, interleukin-8 and mucosal inflammation in Helicobacter pylori-positive peptic ulcer patients
    HELICOBACTER
    
    S. Yamamoto et al., "Interactions among gastric somatostatin, interleukin-8 and mucosal inflammation in Helicobacter pylori-positive peptic ulcer patients", HELICOBACT, 6(2), 2001, pp. 136-145
86. Thomas, DR
    Issues and dilemmas in the prevention and treatment of pressure ulcers: A review
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
    
    D.R. Thomas, "Issues and dilemmas in the prevention and treatment of pressure ulcers: A review", J GERONT A, 56(6), 2001, pp. M328-M340
87. Leff, B; Burton, JR
    The future history of home care and physician house calls in the United States
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
    
    B. Leff e J.R. Burton, "The future history of home care and physician house calls in the United States", J GERONT A, 56(10), 2001, pp. M603-M608
88. Morrison, A; Wertheimer, AI
    Evaluation of studies investigating the effectiveness of pharmacists' clinical services
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    
    A. Morrison e A.I. Wertheimer, "Evaluation of studies investigating the effectiveness of pharmacists' clinical services", AM J HEAL S, 58(7), 2001, pp. 569-577
89. 
    ASHP therapeutic position statement on the identification and treatment ofHelicobacter pylori-associated peptic ulcer disease in adults
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    
    AM J HEAL S, 58(4), 2001, pp. 331-337
90. Wong, DH
    Comparison of eptifibatide and abciximab with decision analysis
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    
    D.H. Wong, "Comparison of eptifibatide and abciximab with decision analysis", AM J HEAL S, 58(15), 2001, pp. 1432-1436
91. Carlos, RC; Bree, RL; Abrahamse, PH; Fendrick, AM
    Cost-effectiveness of saline-assisted hysterosonography and office hysteroscopy in the evaluation of postmenopausal bleeding: A decision analysis
    ACADEMIC RADIOLOGY
    
    R.C. Carlos et al., "Cost-effectiveness of saline-assisted hysterosonography and office hysteroscopy in the evaluation of postmenopausal bleeding: A decision analysis", ACAD RADIOL, 8(9), 2001, pp. 835-844
92. Bree, RL; Arnold, RJG; Pettit, KG; Kaniecki, DJ; O'Haeri, C; LaFrance, ND; Toaff, AL
    Use of a decision-analytic model to support the use of a new oral US contrast agent in patients with abdominal pain
    ACADEMIC RADIOLOGY
    
    R.L. Bree et al., "Use of a decision-analytic model to support the use of a new oral US contrast agent in patients with abdominal pain", ACAD RADIOL, 8(3), 2001, pp. 234-242
93. Liu, AY; Yousem, DM; Chalian, AA; Langlotz, CP
    Economic consequences of diagnostic imaging for vocal cord paralysis
    ACADEMIC RADIOLOGY
    
    A.Y. Liu et al., "Economic consequences of diagnostic imaging for vocal cord paralysis", ACAD RADIOL, 8(2), 2001, pp. 137-148
94. Phillips, SD; Burns, BJ; Edgar, ER; Mueser, KT; Linkins, KW; Rosenheck, RA; Drake, RE; Herr, ECM
    Moving assertive community treatment into standard practice
    PSYCHIATRIC SERVICES
    
    S.D. Phillips et al., "Moving assertive community treatment into standard practice", PSYCH SERV, 52(6), 2001, pp. 771-779
95. Menzies, D
    Controlling tuberculosis among foreign born within industrialized countries - Expensive band-aids
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    D. Menzies, "Controlling tuberculosis among foreign born within industrialized countries - Expensive band-aids", AM J R CRIT, 164(6), 2001, pp. 914-915
96. Britton, J; Jarvis, M; McNeill, A; Bates, C; Cuthbertson, L; Godfrey, C
    Treating nicotine addiction - Not a medical problem?
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    J. Britton et al., "Treating nicotine addiction - Not a medical problem?", AM J R CRIT, 164(1), 2001, pp. 13-15
97. Angus, DC; Musthafa, AA; Clermont, G; Griffin, MF; Linde-Zwirble, WT; Dremsizov, TT; Pinsky, MR
    Quality-adjusted survival in the first year after the acute respiratory distress syndrome
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    
    D.C. Angus et al., "Quality-adjusted survival in the first year after the acute respiratory distress syndrome", AM J R CRIT, 163(6), 2001, pp. 1389-1394
98. Butler, CC; van der Voort, JH
    Steroids for otitis media with effusion - A systematic review
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
    
    C.C. Butler e J.H. van der Voort, "Steroids for otitis media with effusion - A systematic review", ARCH PED AD, 155(6), 2001, pp. 641-647
99. Heller, GV; Udelson, JE; Ziffer, J; Hendel, R; Spiegler, E; Port, S; Christian, T; Selker, HP
    Assessing suspected acute cardiac ischemia in the emergency department: Logistics, testing modalities, implications for perfusion imaging
    JOURNAL OF NUCLEAR CARDIOLOGY
    
    G.V. Heller et al., "Assessing suspected acute cardiac ischemia in the emergency department: Logistics, testing modalities, implications for perfusion imaging", J NUCL CARD, 8(2), 2001, pp. 274-285
100. Lipschik, GY; Kelley, MA
     Models of critical care delivery: Physician staffing in the ICU
     SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
     
     G.Y. Lipschik e M.A. Kelley, "Models of critical care delivery: Physician staffing in the ICU", SEM RESP CR, 22(1), 2001, pp. 95-100